603334.SH
丰倍生物
SSE · Healthcare · Biotechnology · CN
CNY 31.22
−4.44%Margins
Gross margin
7.2%
EBITDA margin
5.1%
EBIT margin
4.4%
Net margin
4.0%
FCF margin
1.7%
8.3%
Return on equity
6.7%
Return on assets
8.6%
Return on invested capital
1.65x
Asset turnover
CNY 88.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026